Key statistics
On Thursday, Marinomed Biotech AG (MARI:VIE) closed at 9.48, 374.00% above the 52 week low of 2.00 set on Aug 16, 2024.
52-week range
Open | 8.10 |
---|---|
High | 9.48 |
Low | 8.10 |
Bid | 9.00 |
Offer | 9.48 |
Previous close | 9.48 |
Average volume | 3.23k |
---|---|
Shares outstanding | 1.54m |
Free float | 1.00m |
P/E (TTM) | -- |
Market cap | 14.60m EUR |
EPS (TTM) | -4.46 EUR |
Data delayed at least 15 minutes, as of Sep 26 2024 16:15 BST.
More ▼
- EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
- EQS-News: Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
- EQS-DD: Marinomed Biotech AG: Andreas Grassauer, buy
- EQS-DD: Marinomed Biotech AG: Simon Nebel, buy
- EQS-DD: Marinomed Biotech AG: Eva Prieschl-Grassauer, buy
- EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
- EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
- EQS-News: Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
- EQS-Adhoc: Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights
- EQS-News: Marinomed Biotech AG reports preliminary financial figures for the first half of 2024
More ▼